close
Breaking news

A new line of argument has already come to dominate the public sphere: it’...read more The government has gone one step further to detect community spread of the coro...read more The government has issued an order to abolish the six allowances, including the...read more Aarogya Setu application launched by NIC is aimed to track COVID-19 affected pe...read more SEOUL| South Korea’s unemployment rate was unchanged in April as the coronavi...read more Amid the outbreak of Corona pandemic in the country, Indian government has been...read more Prime Minister Narendra Modi in his address to the nation on Tuesday indicated ...read more Corona infection in the country is taking a macabre form. So far, more than 74 ...read more Congress General Secretary Priyanka Gandhi Vadra has written a letter to UP Chi...read more On Tuesday, Prime Minister Narendra Modi announced a package of Rs 20 lakh cror...read more

USA Drug Regulators Agree to Use Malaria Drug For Corona Treatment

ZURICH: Pharmaceutical giant Novartis has reached an agreement with US regulators to hold a randomised trial of malaria drug hydroxychloroquine against coronavirus in 440 hospitalised patients.

US FDA has given the medicine authorisation for treatment of the novel virus, however no such scientific proof exist.

“We recognize the importance of answering the scientific question of whether hydroxychloroquine will be beneficial for patients with COVID-19 disease,” said John Tsai, Novartis’ top drug developer.

The drug has been promoted by the US President Donald Trump, after which India has lifted the ban on export of this drug. Trump has been strongly advocating hydroxychloroquine as a treatment of the virus, however many scientists are urging caution against larger usage of the drug.

Story Page

Download Our Mobile App